title: Use of phenytoin and carbamazepine in treatment of epilepsy.
abstract: This article reviews the clinical pharmacology of carbamazepine and phenytoin, widely regarded as the drugs of choice for partial and secondary generalized seizures.
mesh_terms: D000741:Anemia, Aplastic / Q000139:chemically induced; D002220:Carbamazepine / Q000009:adverse effects / Q000097:blood / Q000627:therapeutic use*; D002524:Cerebellar Ataxia / Q000139:chemically induced; D056486:Chemical and Drug Induced Liver Injury; D003072:Cognition Disorders / Q000139:chemically induced; D003875:Drug Eruptions / Q000209:etiology; D004347:Drug Interactions; D004827:Epilepsy / Q000188:drug therapy*; D005885:Gingival Hyperplasia / Q000139:chemically induced; D006207:Half-Life; D006801:Humans; D007177:Inappropriate ADH Syndrome / Q000139:chemically induced; D010672:Phenytoin / Q000009:adverse effects / Q000097:blood / Q000627:therapeutic use*; D014202:Tremor / Q000139:chemically induced
chemical_list: D002220:Carbamazepine; D010672:Phenytoin